
FDA is about to approve the first alternative to emergency epinephrine without needles.
Early trial of STAT+ drug shows it reduces harmful protein buildup within the heart
FDA is about to approve the first alternative to emergency epinephrine without needles.
Early trial of STAT+ drug shows it reduces harmful protein buildup within the heart